Study of Teclistamab in Combination in Elderly Patients With Multiple Myeloma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of Teclistamab in Combination in Elderly Patients With Multiple Myeloma	Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease	Active, not recruiting	Phase 2	2026-09-25		NCT05572229

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Janssen Pharmaceutica N.V., Belgium	13
University Hospital, Lille	194

22 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Aphp - Chu Henri Mondor	Paris	France	1
Centre Hospitalier de La Cote Basque	Bayonne	France	2
Centre Hospitalier de Versailles	Le Chesnay	France	2
Centre Leon Berard	Lyon	France	34
Ch D'Avignon	Avignon	France	1
CHR Metz-Thionville	Metz	France	7
Chru Angers	Angers	France	2
Chru Bretonneau	Tours	France	8
Chru de Nancy, Hopitaux de Brabois	Nancy	France	1
Chu Amiens - Hopital Sud	Amiens	France	3
Chu Bordeaux	Pessac	France	8
Chu de Besancon	Besançon	France	8
Chu de Caen	Caen	France	32
Chu de Grenoble	La Tronche	France	3
Chu de Lille, Hopital Claude Huriez	Lille	France	1
Chu de Nantes Site Hotel Dieu	Nantes	France	1
CHU de Poitiers	Poitiers	France	40
Chu Dijon Bourgogne	Dijon	France	31
CHU Limoges	Limoges	France	42
CHU Montpellier	Montpellier	France	56
Hopitaux Universitaire de Strasbourg - Hopital Hautepierre	Strasbourg	France	1
Oncopole Chu Toulouse	Toulouse	France	1

Clinical trials